References
Jun 26, 2009·British Journal of Clinical Pharmacology·Roberta JoppiSilvio Garattini
Jan 21, 2010·PharmacoEconomics·Tania StafinskiDevidas Menon
Jan 21, 2010·PharmacoEconomics·Christopher J McCabeUNKNOWN Banff AED Summit
Mar 17, 2010·Health Policy·Josh J CarlsonDavid L Veenstra
Apr 16, 2010·The New England Journal of Medicine·Ans T van der PloegSasa A Zivkovic
Jun 10, 2010·BMC Health Services Research·Jakub AdamskiLars L Gustafsson
Sep 2, 2010·Applied Health Economics and Health Policy·Javier OrofinoItziar Oyagüez
Nov 18, 2010·BMJ : British Medical Journal·Jonathan C P RoosTimothy M Cox
Jan 26, 2011·International Journal of Technology Assessment in Health Care·Marianne KlempUNKNOWN HTAi Policy Forum
Mar 15, 2011·British Journal of Clinical Pharmacology·Alain G Dupont, Philippe B Van Wilder
Jun 7, 2011·JAMA : the Journal of the American Medical Association·Aaron S KesselheimJerry Avorn
Jun 21, 2011·Applied Health Economics and Health Policy·Eline PicavetSteven Simoens
Jun 21, 2011·Orphanet Journal of Rare Diseases·Steven Simoens
Sep 29, 2011·Orphanet Journal of Rare Diseases·Carina ScheyAdam Hutchings
Mar 1, 2012·PloS One·Aaron S KesselheimJerry Avorn
May 16, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Simon WalkerSteve Palmer
Aug 15, 2012·BMJ : British Medical Journal·Tony Sheldon
Oct 24, 2012·European Journal of Clinical Pharmacology·Roberta JoppiSilvio Garattini
Jan 17, 2013·Applied Health Economics and Health Policy·Brian Godman, Lars L Gustafsson
Jan 19, 2013·Applied Health Economics and Health Policy·Steven SimoensThomas Morel
Feb 21, 2013·Orphanet Journal of Rare Diseases·Saskia M RombachMarcel G W Dijkgraaf
Jul 10, 2013·Drug Discovery Today·M PutzeistH G M Leufkens
Aug 21, 2013·Orphanet Journal of Rare Diseases·Tim A KantersLeona Hakkaart
Aug 21, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Louis P GarrisonMiguel Sleeper
Oct 3, 2013·JAMA : the Journal of the American Medical Association·Brian P O'SullivanCarlos E Milla
Citations
Mar 31, 2015·BMJ Open·Urs BrüggerAlois Gratwohl
Apr 29, 2014·Orphanet Journal of Rare Diseases·Eline PicavetSteven Simoens
Sep 12, 2014·Orphanet Journal of Rare Diseases·Eline PicavetSteven Simoens
Dec 10, 2014·Expert Review of Clinical Pharmacology·Brian GodmanLars L Gustafsson
Oct 21, 2014·Expert Review of Pharmacoeconomics & Outcomes Research·Afschin Gandjour
Jun 23, 2015·Acta Oncologica·Bettina ButzkeWolf H Rogowski
Dec 3, 2014·Social Science & Medicine·Alessandra Ferrario, Panos Kanavos
May 4, 2015·Orphanet Journal of Rare Diseases·Laura GutierrezWarren Cowell
Sep 17, 2015·Orphanet Journal of Rare Diseases·Tim A KantersLeona Hakkaart
Sep 2, 2016·Applied Health Economics and Health Policy·Mondher ToumiÅsa Kornfeld
Oct 18, 2016·Frontiers in Public Health·Georgi IskrovRumen Stefanov
Oct 23, 2016·Clinical Pharmacology and Therapeutics·S D FaulknerR Barker
Oct 10, 2015·PloS One·Todd GammieZaheer Ud-Din Babar
May 27, 2017·BMC Health Services Research·N ManiadakisA Holtorf
Apr 7, 2018·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Andrea YoungTania Stafinski
Aug 24, 2017·Acta Oncologica·Yolande Lievens
Dec 24, 2017·Orphanet Journal of Rare Diseases·Andrea YoungTania Stafinski
Feb 9, 2018·Pharmaceutical Research·Szymon JarosławskiClaude Dussart
Nov 7, 2019·Applied Health Economics and Health Policy·Caridad PontesBrian Godman
Apr 16, 2020·Molecular Oncology·Yolande LievensCai Grau
Jul 14, 2020·Expert Review of Pharmacoeconomics & Outcomes Research·Hussain Abdulrahman Al-OmarIbrahim Abdulrahman Aljuffali
Sep 10, 2020·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Nasuh C BuyukkaramikliMen Thi Hoang
Sep 24, 2020·International Journal of Technology Assessment in Health Care·Weiwei Xu, Jing Wu
Aug 20, 2016·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Elena Nicod
Mar 12, 2017·Orphanet Journal of Rare Diseases·Lieven AnnemansLugdivine Le Dez
Jan 5, 2018·The Patient·Andrea YoungTania Stafinski
Nov 28, 2018·Journal of Market Access & Health Policy·Szymon Jarosławski, Mondher Toumi
Dec 6, 2018·Health Economics Review·Kyung-Bok Son
Sep 20, 2019·PharmacoEconomics·Fernando AntonanzasRoberto Rodríguez-Ibeas
Apr 7, 2018·PharmacoEconomics Open·Trevor Jozef PiatkiewiczTove Holm-Larsen
Oct 5, 2018·Applied Health Economics and Health Policy·Irene ErikssonBjörn Wettermark
Mar 1, 2017·Therapeutic Innovation & Regulatory Science·Jessica PaceWendy Lipworth
Feb 19, 2019·Journal of Market Access & Health Policy·Jesper JørgensenPanos Kefalas
Nov 7, 2018·Orphanet Journal of Rare Diseases·Márta SzegediMária Judit Molnár
Aug 30, 2020·Orphanet Journal of Rare Diseases·Xavier BadiaCésar Hernández
Apr 20, 2017·Frontiers in Pharmacology·Kim PauwelsSteven Simoens
Nov 4, 2017·Orphanet Journal of Rare Diseases·Thomas Morel, Stefan J Cano
Jul 16, 2019·Journal of Market Access & Health Policy·Jesper Jørgensen, Panos Kefalas
Mar 17, 2019·European Journal of Clinical Pharmacology·Philippe Van WilderAlain Dupont
Apr 11, 2018·Frontiers in Pharmacology·Jacoline C BouvySarah Garner
Aug 1, 2020·PharmacoEconomics·Carolina Zampirolli DiasAugusto Afonso Guerra-Junior
May 10, 2017·PharmacoEconomics·Fernando AntoñanzasMaarten Postma
May 28, 2019·International Journal of Technology Assessment in Health Care·Linda MundyBrendon Kearney
Dec 29, 2020·Frontiers in Pharmacology·Sissel MichelsenIsabelle Huys
Feb 26, 2020·Health Policy·Emelie AnderssonPeter Lindgren
Jan 14, 2020·Health Policy·Mackenzie Mills, Panos Kanavos
Jan 30, 2021·International Journal of Technology Assessment in Health Care·Olina Efthymiadou, Panos Kanavos
Feb 4, 2021·International Journal of Environmental Research and Public Health·Patrizio ArmeniYllka Kodra
Feb 25, 2021·MDM Policy & Practice·Gregory S Zaric
Mar 2, 2021·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Isaac Aranda-ReneoJulio López-Bastida